AGP Limited (PSX:AGP)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
183.19
-4.19 (-2.24%)
At close: May 11, 2026
Market Cap52.47B -10.0%
Revenue (ttm)28.58B +8.8%
Net Income3.74B +19.8%
EPS13.36 +19.9%
Shares Out280.00M
PE Ratio14.03
Forward PE12.41
Dividend8.00 (4.27%)
Ex-Dividend DateApr 13, 2026
Volume588,016
Average Volume607,999
Open186.00
Previous Close187.38
Day's Range182.56 - 186.40
52-Week Range142.00 - 258.67
Beta0.42
RSI45.20
Earnings DateApr 29, 2026

About AGP Limited

AGP Limited operates as an independent pharmaceutical manufacturing company in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antipsychotics, biguanide and S-urea combs, and bile stone the... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1989
Employees 2,143
Stock Exchange Pakistan Stock Exchange
Ticker Symbol AGP
Full Company Profile

Financial Performance

In 2025, AGP Limited's revenue was 28.89 billion, an increase of 15.40% compared to the previous year's 25.03 billion. Earnings were 3.74 billion, an increase of 39.91%.

Financial Statements